Symphony Allegro Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

Symphony Allegro General Information

Description

Developer of Alexza Pharmaceuticals' AZ-002 and AZ-004 products. The company was formed through a collaboration between Symphony Capital Partners and Alexza Pharmaceuticals to develop Alexza's AZ-002 Staccato Alprazolam and AZ-004 Staccato Loxapine programs. It supports AZ-002 through Phase IIb clinical trials for the treatment of panic attack in patients with panic disorder and AZ-004 through Phase IIb clinical trials for the treatment of acute agitation in patients with schizophrenia.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Corporate Office
  • 7361 Calhoun Place
  • Suite 325
  • Rockville, MD 20855
  • United States
+1 (301) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Symphony Allegro Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Symphony Allegro‘s full profile, request access.

Request a free trial

Symphony Allegro Executive Team (3)

Name Title Board Seat Contact Info
Frank Hurley Ph.D Chief Executive Officer
Daniel Salins Chief Financial Officer
You’re viewing 2 of 3 executive team members. Get the full list »

Symphony Allegro Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Symphony Allegro‘s full profile, request access.

Request a free trial

Symphony Allegro FAQs

  • When was Symphony Allegro founded?

    Symphony Allegro was founded in 2006.

  • Who is the CEO of Symphony Allegro?

    Frank Hurley Ph.D is the CEO of Symphony Allegro.

  • Where is Symphony Allegro headquartered?

    Symphony Allegro is headquartered in Rockville, MD.

  • What industry is Symphony Allegro in?

    Symphony Allegro’s primary industry is Drug Discovery.

  • Is Symphony Allegro a private or public company?

    Symphony Allegro is a Private company.

  • What is the current valuation of Symphony Allegro?

    The current valuation of Symphony Allegro is 000.00.

  • What is Symphony Allegro’s current revenue?

    The current revenue for Symphony Allegro is 000000.

  • How much funding has Symphony Allegro raised over time?

    Symphony Allegro has raised $50M.

  • Who are Symphony Allegro’s investors?

    Symphony Capital has invested in Symphony Allegro.

  • When was Symphony Allegro acquired?

    Symphony Allegro was acquired on 26-Aug-2009.

  • Who acquired Symphony Allegro?

    Symphony Allegro was acquired by Alexza Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »